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Introduction 
Frailty has been under investigated as a risk factor for medication-related harm (MRH) in 
older adults[1].  We sought to determine whether frailty is independently associated with 
MRH in a large multicentre prospective cohort, the PRIME study.   
   
Methods 
The PRIME study recruited 1280 older adults at hospital discharge from 5 hospitals in 
England between 2013 to 2015[2].  MRH and associated healthcare use within 8-weeks 
post-discharge were identified by senior pharmacists using (1) hospital readmission data, (2) 
primary care records, (3) patient telephone interviews.  Based on the Rockwood 
approach[3], we developed a frailty index including 55 deficits from multiple domains 
(morbidity, cognition, mood, strength and mobility, nutrition, daily function).  Frailty was 
defined using the established cut-off of ≥20% deficits[4], and internally validated using 
Kaplan-Meier plots comparing survival in frail and non-frail patients.  We then used logistic 
regression analysis to investigate the relationship between frailty and MRH requiring 
healthcare.  
 
Results 
1116 patients completed follow-up (median age 81.9 years, range 65-103 years, 58.4% 
female).  446 patients (40%) were frail in our cohort.  36% of frail patients experienced MRH 
compared with 25% in non-frail patients.  There was a strong relationship between frailty 
and MRH (OR 1.67, 95% CI 1.29-2.17, p<0.001).  A significant relationship between frailty 
and MRH remained on multivariable regression, adjusting for polypharmacy, age and 
gender (OR 1.37, 95% CI 1.04-1.81, p=0.027). Frail patients had significantly reduced 18-
month survival (Log-Rank test p<0.001). 
 
Key Conclusions 
Frailty is a predictor of MRH requiring healthcare, independent of polypharmacy.  
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